Great Point Partners, LLC 13D and 13G filings for Unicycive Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 4:39 pm Purchase | 2024-12-31 | 13G | Unicycive Therapeutics, Inc. UNCY | Great Point Partners, LLC | 11,473,166 9.990% | 1,950,734 (+20.49%) | Filing |
| 2024-11-14 5:05 pm Purchase | 2024-09-30 | 13G | Unicycive Therapeutics, Inc. UNCY | Great Point Partners, LLC | 9,522,432 9.990% | 963,432 (+11.26%) | Filing |
| 2024-07-18 4:10 pm Purchase | 2024-07-16 | 13G | Unicycive Therapeutics, Inc. UNCY | Great Point Partners, LLC | 8,559,000 9.990% | 8,559,000 (New Position) | Filing |